Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
87.21
-1.23 (-1.39%)
At close: Mar 18, 2026, 4:00 PM EDT
87.13
-0.08 (-0.09%)
After-hours: Mar 18, 2026, 7:48 PM EDT
Medtronic Stock Forecast
Stock Price Forecast
The 17 analysts that cover Medtronic stock have a consensus rating of "Buy" and an average price target of $109.82, which forecasts a 25.93% increase in the stock price over the next year. The lowest target is $100 and the highest is $120.
Price Target: $109.82 (+25.93%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Medtronic stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 8 | 8 | 8 | 9 | 9 | 9 |
| Hold | 6 | 8 | 8 | 8 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 18 | 18 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +37.60% | Mar 10, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $105 → $100 | Hold | Maintains | $105 → $100 | +14.67% | Feb 18, 2026 |
| Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | +35.31% | Feb 18, 2026 |
| Baird | Baird | Hold Maintains $103 → $100 | Hold | Maintains | $103 → $100 | +14.67% | Feb 18, 2026 |
| Needham | Needham | Strong Buy Maintains $121 → $120 | Strong Buy | Maintains | $121 → $120 | +37.60% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
36.53B
from 33.54B
Increased by 8.91%
Revenue Next Year
38.99B
from 36.53B
Increased by 6.75%
EPS This Year
5.70
from 3.61
Increased by 57.77%
EPS Next Year
6.14
from 5.70
Increased by 7.81%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.1B | 41.3B | |||
| Avg | 36.5B | 39.0B | |||
| Low | 35.1B | 36.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 13.6% | 13.1% | |||
| Avg | 8.9% | 6.8% | |||
| Low | 4.6% | 0.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.94 | 6.56 | |||
| Avg | 5.70 | 6.14 | |||
| Low | 5.52 | 5.88 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.6% | 15.2% | |||
| Avg | 57.8% | 7.8% | |||
| Low | 52.8% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.